Table 4 Relative expression of miR-21 and RECK in the malignant prostatic tissue in three profiles
↓miR-21 and ↓RECK | ↑miR-21 and ↓RECK | ↓miR-21 and ↑RECK | P value | |
|---|---|---|---|---|
Gleason Score | ||||
< 7 | 56.0% | 33.3% | 31.3% | 0.215 |
≥ 7 | 44.0% | 67.7% | 68.7% | |
Pathological Stage | ||||
pT2 | 52.0% | 8.3% | 53.3% | 0.025 |
pT3 | 48.0% | 91.7% | 46.7% | |
PSA value | ||||
<10 | 60.0% | 50.0% | 37.5% | 0.371 |
≥10 | 40.0% | 50.0% | 62.5% | |
Biochemical Recurrence | ||||
No | 75.0% | 36.4% | 50.0% | 0.087 |
Yes | 25.0% | 63.6% | 50.0% |